Le Lézard
Classified in: Science and technology
Subjects: LEG, AVO

ID.me Announces Support for Federal Privacy Legislation


 Congress Should Act to Allow Every American to Better Control If and How Their Personal Information is Shared

MCLEAN, Va., July 13, 2022 /PRNewswire/ -- ID.me, the secure digital identity network, announced its support for federal privacy legislation today to give Americans control over their private information and rein in data brokers who sell personal information for profit and without consent.

"ID.me supports federal privacy legislation that creates clear market protections for consumers," said Blake Hall, co-founder and CEO of ID.me. "We believe that individuals have a fundamental right to privacy, and to control their own data across organizations and websites through the identity provider of their choice. While there are still important issues to iron out, we urge Congress to pass legislation that puts users in the driver's seat and ensures they know how their personal information is being used."

ID.me supports federal privacy legislation that includes the following principles:

Federal privacy legislation is being considered in Congress. House Energy and Commerce (E&C) Committee Chair Frank Pallone (D-NJ-06), recently introduced the American Data Privacy and Protection Act with Senate Commerce Committee Ranking Member Roger Wicker (R-MS) and E&C Ranking Member Cathy McMorris Rodgers (R-WA-05). The Consumer Protection and Commerce Subcommittee reported the bill favorably on June 23, 2022, advancing it for full committee consideration. Senate Commerce, Science, and Transportation Committee Chair Maria Cantwell (D-WA) is also reportedly considering a markup for a separate framework this summer.

About ID.me

The ID.me secure digital identity network includes partnerships in 30 states, 10 federal agencies, and over 500 name-brand retailers. The company provides identity proofing, authentication and group affiliation verification for organizations across sectors. The company's technology meets the federal standards for consumer authentication and is approved as a NIST 800-63-3 IAL2 / AAL2 conformant credential service provider by the Kantara Initiative. ID.me's Identity Gateway also maintains a Federal Risk and Authorization Management Program (FedRAMP) Moderate Authority to Operate (ATO). ID.me is the only company that has obtained all three major standard certifications for managing information security, including FedRAMP, SOC 2 Type II and ISO/IEC 27001:2013 Certification.

ID.me strives towards its mission of "No Identity Left Behind" to enable all people to have secure access to services. To learn more, visit https://www.ID.me.

 

SOURCE ID.me


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: